MedWatch

Medtech giant launches attack on Ambu's future hope

One of the world's heavyweights in medical equipment has now announced itself as a player in the market for single-use equipment for duodenum examinations with the so-called duodenoscopes. A massive threat to Ambu according to analyst firm. Ambu's CEO calls it good news.

Lars Marcher, President and CEO of medtech group Ambu, welcomes the competition from Boston Scientific. | Foto: /ritzau/Claus Bech

There have been rumors, but now it is undeniable.

The US medtech giant and Coloplast competitor in the field of urology, Boston Scientific, is now entering the market for single-use endoscopes, which is Danish Ambu's core business.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier